227 related articles for article (PubMed ID: 15804533)
21. X-ray crystallographic analysis of IMP-1 metallo-β-lactamase complexed with a 3-aminophthalic acid derivative, structure-based drug design, and synthesis of 3,6-disubstituted phthalic acid derivative inhibitors.
Hiraiwa Y; Saito J; Watanabe T; Yamada M; Morinaka A; Fukushima T; Kudo T
Bioorg Med Chem Lett; 2014 Oct; 24(20):4891-4. PubMed ID: 25246278
[TBL] [Abstract][Full Text] [Related]
22. Synthesis and in-vitro activity of novel 1beta-methylcarbapenems having spiro[2,4]heptane moieties.
Park HB; Jo NH; Hong JH; Choi JH; Cho JH; Yoo KH; Oh CH
Arch Pharm (Weinheim); 2007 Oct; 340(10):530-7. PubMed ID: 17849445
[TBL] [Abstract][Full Text] [Related]
23. Synthesis and biological evaluation of 1beta-methylcarbapenems having cyclic thiourea moieties and their related compounds.
Han T; Cho JH; Oh CH
Eur J Med Chem; 2006 Jul; 41(7):825-32. PubMed ID: 16737759
[TBL] [Abstract][Full Text] [Related]
24. Permeability of a novel beta-lactamase inhibitor LK-157 and its ester prodrugs across rat jejunum in vitro.
Iglicar P; Legen I; Vilfan G; Selic L; Prezelj A
J Pharm Pharmacol; 2009 Sep; 61(9):1211-8. PubMed ID: 19703371
[TBL] [Abstract][Full Text] [Related]
25. Carbapenem resistance in Acinetobacter baumannii: mechanisms and epidemiology.
Poirel L; Nordmann P
Clin Microbiol Infect; 2006 Sep; 12(9):826-36. PubMed ID: 16882287
[TBL] [Abstract][Full Text] [Related]
26. [Detection of plasmid-mediated carbapenem-hydrolyzing beta-lactamase KPC-2 in a strain of carbapenem-resistant Enterobacter cloacae].
Cai JC; Zhou HW; Chen GX; Zhang R
Zhonghua Yi Xue Za Zhi; 2008 Jan; 88(2):135-8. PubMed ID: 18353225
[TBL] [Abstract][Full Text] [Related]
27. Contribution of extended-spectrum AmpC (ESAC) beta-lactamases to carbapenem resistance in Escherichia coli.
Mammeri H; Nordmann P; Berkani A; Eb F
FEMS Microbiol Lett; 2008 May; 282(2):238-40. PubMed ID: 18371063
[TBL] [Abstract][Full Text] [Related]
28. First report of the carbapenem-resistant Pseudomonas aeruginosa producing IMP-7 metallo-beta-lactamase in Slovakia.
Ohlasova D; Kmet V; Niks M
Int J Antimicrob Agents; 2007 Oct; 30(4):370-1. PubMed ID: 17709230
[No Abstract] [Full Text] [Related]
29. Redefining penems.
Dalhoff A; Janjic N; Echols R
Biochem Pharmacol; 2006 Mar; 71(7):1085-95. PubMed ID: 16413506
[TBL] [Abstract][Full Text] [Related]
30. Potency of carbapenems for the prevention of carbapenem-resistant mutants of Pseudomonas aeruginosa: the high potency of a new carbapenem doripenem.
Sakyo S; Tomita H; Tanimoto K; Fujimoto S; Ike Y
J Antibiot (Tokyo); 2006 Apr; 59(4):220-8. PubMed ID: 16830889
[TBL] [Abstract][Full Text] [Related]
31. In vitro antibacterial activity and beta-lactamase stability of the new carbapenem LJC10,627.
Yoshida M; Mitsuhashi S
Eur J Clin Microbiol Infect Dis; 1990 Aug; 9(8):625-9. PubMed ID: 2209630
[TBL] [Abstract][Full Text] [Related]
32. Ongoing epidemic of blaVIM-1-positive Klebsiella pneumoniae in Athens, Greece: a prospective survey.
Psichogiou M; Tassios PT; Avlamis A; Stefanou I; Kosmidis C; Platsouka E; Paniara O; Xanthaki A; Toutouza M; Daikos GL; Tzouvelekis LS
J Antimicrob Chemother; 2008 Jan; 61(1):59-63. PubMed ID: 17999975
[TBL] [Abstract][Full Text] [Related]
33. Contributions of IMP-10 metallo-beta-lactamase, the outer membrane barrier and the MexAB-OprM efflux system to high-level carbapenem resistance in Pseudomonas aeruginosa.
Zhao WH; Hu Z; Chen G; Ito R; Hu ZQ
Chemotherapy; 2009; 55(3):168-74. PubMed ID: 19420932
[TBL] [Abstract][Full Text] [Related]
34. Classification of OprD sequence and correlation with antimicrobial activity of carbapenem agents in Pseudomonas aeruginosa clinical isolates collected in Japan.
Sanbongi Y; Shimizu A; Suzuki T; Nagaso H; Ida T; Maebashi K; Gotoh N
Microbiol Immunol; 2009 Jul; 53(7):361-7. PubMed ID: 19563394
[TBL] [Abstract][Full Text] [Related]
35. A carbapenem-susceptible Pseudomonas aeruginosa strain carrying the bla(SPM) gene.
Pellegrino FL; Casali N; Nouér SA; Riley LW; Moreira BM
Diagn Microbiol Infect Dis; 2008 Jun; 61(2):214-6. PubMed ID: 18308497
[TBL] [Abstract][Full Text] [Related]
36. SME-3, a novel member of the Serratia marcescens SME family of carbapenem-hydrolyzing beta-lactamases.
Queenan AM; Shang W; Schreckenberger P; Lolans K; Bush K; Quinn J
Antimicrob Agents Chemother; 2006 Oct; 50(10):3485-7. PubMed ID: 17005839
[TBL] [Abstract][Full Text] [Related]
37. Synthesis and SAR of novel benzoxaboroles as a new class of β-lactamase inhibitors.
Xia Y; Cao K; Zhou Y; Alley MR; Rock F; Mohan M; Meewan M; Baker SJ; Lux S; Ding CZ; Jia G; Kully M; Plattner JJ
Bioorg Med Chem Lett; 2011 Apr; 21(8):2533-6. PubMed ID: 21392987
[TBL] [Abstract][Full Text] [Related]
38. Bacteremia due to extended-spectrum beta-lactamase-producing Enterobacteriaceae other than Escherichia coli and Klebsiella.
Huang SS; Lee MH; Leu HS
J Microbiol Immunol Infect; 2006 Dec; 39(6):496-502. PubMed ID: 17164953
[TBL] [Abstract][Full Text] [Related]
39. In vivo development of carbapenem resistance in clinical isolates of Enterobacter aerogenes producing multiple beta-lactamases.
Chen YG; Zhang Y; Yu YS; Qu TT; Wei ZQ; Shen P; Li LJ
Int J Antimicrob Agents; 2008 Oct; 32(4):302-7. PubMed ID: 18556176
[TBL] [Abstract][Full Text] [Related]
40. Synthesis and in vitro activity of a series 1beta-methylcarbapenem derivatives.
Jeon HC; Kim JW; Hong JH; Cho JH; Oh CH
Eur J Med Chem; 2006 Oct; 41(10):1201-9. PubMed ID: 16797791
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
